|
|
Volumn 63, Issue 3, 2011, Pages 460-
|
|
Rituximab for patients with myopathy associated with anti signal recognition particle antibodies: Comment on the article by Valiyil et al
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
CORTICOSTEROID;
CREATINE KINASE;
IMMUNOGLOBULIN;
METHOTREXATE;
METHYLPREDNISOLONE;
RITUXIMAB;
SIGNAL RECOGNITION PARTICLE ANTIBODY;
UNCLASSIFIED DRUG;
IMMUNOLOGIC FACTOR;
MONOCLONAL ANTIBODY;
SIGNAL RECOGNITION PARTICLE;
ADULT;
CASE REPORT;
CREATINE KINASE BLOOD LEVEL;
DRUG DOSE REDUCTION;
DRUG MEGADOSE;
DRUG WITHDRAWAL;
DYSPHAGIA;
DYSPHONIA;
DYSPNEA;
ECHOCARDIOGRAPHY;
EDEMA;
FACE EDEMA;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INFLAMMATORY DISEASE;
LABORATORY TEST;
LETTER;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MULTIPLE CYCLE TREATMENT;
MUSCLE ATROPHY;
MUSCLE BIOPSY;
MUSCLE DISEASE;
MUSCLE STRENGTH;
MUSCLE WEAKNESS;
MYALGIA;
MYOCARDITIS;
MYOPATHY;
MYOSITIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PARAPLEGIA;
POLYMYOSITIS;
IMMUNOLOGY;
MALE;
NOTE;
ANTIBODIES, MONOCLONAL;
FEMALE;
HUMANS;
IMMUNOLOGIC FACTORS;
MALE;
MUSCLE WEAKNESS;
MYOSITIS;
SIGNAL RECOGNITION PARTICLE;
|
|
EID: 84858034208
PISSN: 00043591
EISSN: 21514658
Source Type: Journal
DOI: 10.1002/acr.20378 Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
